STOCK TITAN

Welltower Reports Fourth Quarter 2021 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Welltower Inc. (NYSE:WELL) reported a net income of $0.13 per diluted share and normalized FFO of $0.83 for Q4 2021. Spot occupancy in the Seniors Housing Operating portfolio rose to 77.7%, with same-store revenue growth of 4.8%. The company achieved $5.7 billion in pro rata gross investments for 2021 and exited its relationship with Genesis Healthcare with an 8.5% unlevered IRR. However, Q4 expenses surged due to higher COVID-19 costs, affecting net income and FFO. For Q1 2022, Welltower expects net income per share between $0.17 to $0.22 and normalized FFO between $0.79 to $0.84.

Positive
  • Seniors housing operating portfolio occupancy rose to 77.7%, up 510 bps since pandemic lows.
  • Q4 same-store revenue growth accelerated to 4.8% compared to the previous year.
  • Achieved $5.7 billion in pro rata gross investments for 2021.
  • Exiting the relationship with Genesis Healthcare generated an 8.5% unlevered IRR.
Negative
  • Q4 expenses were significantly higher due to COVID-19 related costs, negatively impacting net income.
  • Higher labor expenses from increased contract labor usage amounted to $30 million.

TOLEDO, Ohio, Feb. 15, 2022 /PRNewswire/ -- Welltower Inc. (NYSE:WELL) today announced results for the quarter ended December 31, 2021.

Recent Highlights

  • Reported net income attributable to common stockholders of $0.13 per diluted share
  • Reported normalized FFO attributable to common stockholders of $0.83 per diluted share
  • Seniors Housing Operating ("SHO") portfolio spot occupancy increased approximately 70 basis points ("bps") during the quarter to 77.7%, while average pro rata occupancy growth exceeded guidance of 140 bps(1)
  • SHO same store revenue growth accelerated 4.8% in the fourth quarter compared to the prior year
  • Achieved same store REVPOR growth of 3.4% within the SHO portfolio during the fourth quarter as compared to 2.2% in the third quarter
  • Completed $1.5 billion of pro rata gross investments during the fourth quarter including $1.4 billion in acquisitions and loan funding and $142 million in development funding
  • In November, we issued $500 million in 2.75% senior unsecured notes due January 2032, matching our lowest-ever coupon on a 10-year note
  • Sold 11.3 million shares of common stock under our ATM program via forward sale agreements at an initial weighted average price of $85.06 since October 1, 2021 for total gross proceeds of approximately $961 million. As of February 14, 2022, approximately 11.1 million shares remain unsettled, which are expected to generate future gross proceeds of $949 million
  • Awarded a rating of A- from CDP, reflecting our comprehensive disclosure, awareness and management of environmental risks, and best practices associated with environmental leadership

Annual Highlights

  • SHO portfolio spot occupancy increased approximately 510 bps from the pandemic-low of 72.6% on March 12, 2021(1)
  • Completed $5.7 billion of pro rata gross investments during 2021
  • Formed 19 new and proprietary long-term growth relationships with best-in-class developers and operators that are expected to meaningfully contribute to capital deployment opportunities
  • Announced substantial exit of the operating relationship with Genesis Healthcare ("Genesis") through real estate transactions totaling $880 million in value, generating an 8.5% unlevered IRR over full term of Genesis relationship
  • Moody's Investors Services and S&P Global Ratings revised their ratings outlook for Welltower to Stable from Negative and affirmed Welltower's issuer credit ratings as 'Baa1' and 'BBB+', respectively
  • Appointed John F. Burkhart as Executive Vice President, Chief Operating Officer
  • Added 51 net new employees in 2021, with a focus on Business Insights, Development and Investments, representing a greater than 10% expansion in the Welltower team

(1) Occupancy metrics represent occupancy at our share for 546 properties in operation as of December 31, 2020, including unconsolidated properties but excluding acquisitions, executed dispositions, development conversions and one property closed for redevelopment.   

COVID-19 Update

In the current quarter, SHO portfolio expenses were significantly higher than expectations, driven by higher COVID-19 related expenses, including personal protective equipment and testing costs, coupled with elevated labor expenses. Higher labor expenses resulted mainly from increased utilization of contract labor due to a rise in occupancy and challenging labor market conditions stemming from the global surge in COVID-19 cases towards the end of the year. Our share of contract labor totaled $30 million, or approximately $0.07 per diluted share on net income attributable to common stockholders and normalized FFO for the three months ended December 31, 2021, resulting in an unfavorable sequential impact of $10 million or $0.02 per diluted share.

Our share of property-level expenses associated with the COVID-19 pandemic relating to our total SHO portfolio, net of reimbursements including Provider Relief Funds and similar programs in the U.K. and Canada, totaled a benefit of approximately $14 million and $39 million for the three and twelve months ended December 31, 2021, respectively, as compared to an expense of approximately $7 million and $68 million for the three and twelve months ended December 31, 2020, respectively. These costs included higher labor expenses coupled with expenditures related to procurement of personal protective equipment and other supplies, net of any reimbursements. Such amounts had a favorable impact on net income attributable to common stockholders and normalized FFO per diluted share of less than $0.03 and $0.09, for the three and twelve months ended December 31, 2021, respectively, and an unfavorable impact of $0.02 and $0.16 per diluted share for the three and twelve months ended December 31, 2020, respectively.

Capital Activity and Liquidity Inclusive of available borrowings under our line of credit, cash and cash equivalents, and restricted cash, at December 31, 2021, we had $4.0 billion of near-term available liquidity and no material senior unsecured note maturities until 2024. Since the beginning of the fourth quarter, we sold 11.3 million shares of common stock under our ATM program via forward sale agreements at an initial weighted average price of $85.06 per share which are expected to generate gross proceeds of approximately $961 million. As of February 14, 2022, approximately 11.1 million shares remain unsettled, which are expected to generate future gross proceeds of $949 million. On November 19, 2021 we completed the issuance of $500 million senior unsecured notes bearing interest at 2.75% with a maturity date of January 2032.

Dividend On February 15, 2022, the Board of Directors declared a cash dividend for the quarter ended December 31, 2021 of $0.61 per share. This dividend, which will be paid on March 8, 2022 to stockholders of record on March 1, 2022, will be our 203rd consecutive quarterly cash dividend. The declaration and payment of future quarterly dividends remains subject to review and approval by the Board of Directors.

Quarterly Investment and Disposition Activity In the fourth quarter, we completed $1.5 billion of pro rata gross investments including $1.4 billion in acquisitions and loan funding as well as $142 million in development funding. We converted five development projects for an aggregate pro rata investment amount of $189 million. Additionally, during the quarter we completed pro rata property dispositions and loan payoffs of $200 million.

Notable Investment Activity Completed During the Quarter

Watermark Retirement Communities During the fourth quarter, we acquired a portfolio of eight rental and six entrance fee communities from Watermark Retirement Communities for $580 million, located in attractive markets across the U.S. Watermark will be retained to manage the properties under a highly aligned RIDEA 3.0 management agreement. The purchase price represents a 40% discount to estimated replacement cost. The transaction is expected to generate an unlevered IRR in the high single-digit range.

New Perspective Senior Living We formed a new 98/2 joint venture with New Perspective Senior Living and simultaneously acquired three newly developed senior housing communities in fast growing micro markets in the Midwest with densification opportunities. The portfolio was acquired for a pro rata investment of $108 million, and New Perspective has assumed operations under a strongly aligned RIDEA 3.0 contract. Additionally, we entered into a construction contract to fund the development of 34 additional cottages at one of the properties for $8 million. The transaction is anticipated to generate unlevered IRR in the high single-digit range.

Quality Senior Living During the quarter, we formed a new partnership with Quality Senior Living ("QSL") through the acquisition of a five-property portfolio of recently developed Class-A communities across the Mid-Atlantic and Southeastern U.S. for $172 million. Four of the communities will be operated by QSL under a new triple-net master lease with the remaining community managed under a strongly aligned RIDEA 3.0 contract. Additionally, we entered into a strategic long-term exclusive development agreement with QSL.

Floridian Club of Sarasota During the fourth quarter, we acquired a cottage-style active adult community located in Venice, Florida for $115 million. The property is a Class-A, purpose-built, high end resort style senior community with first rate amenities and finishes. The community was recently constructed and is fully leased with a substantial waitlist. We entered into a management agreement with The Barrington Group, who will continue to manage the community.

Wingate Senior Living During the fourth quarter, we acquired two seniors housing properties located in the Boston MSA for $100 million. The communities will be operated by Wingate Senior Living under a new triple-net master lease.

Outpatient Medical Acquisition During the fourth quarter, we acquired a portfolio of eight medical office buildings in Ann Arbor, Michigan for $106 million. The portfolio is 97% occupied, with an average age of seven years and a weighted average remaining lease term of five years.

Other Transactions Additionally during the fourth quarter, we acquired seven seniors housing communities for pro rata investment of $142 million which will be operated under new triple-net master leases with several existing operators. Additionally, we acquired a medical office building in Texas for $6 million. We disposed of four properties previously leased to Genesis, one seniors housing triple-net property and one medical office building for proceeds of $131 million, resulting in a gain on sale of $12 million.

Annual Investment and Disposition Activity During 2021, we completed $5.7 billion of pro rata gross investments including $5.1 billion in acquisitions and loan funding as well as $546 million in development funding. We converted 16 development projects for an aggregate pro rata amount of $625 million. Additionally, during the year we completed pro rata property dispositions and loan payoffs of $1.4 billion.

Notable Annual Investment Activity

Atria Senior Living During the third quarter, we completed the acquisition of a portfolio of 85 seniors housing properties owned by Holiday Retirement for $1.58 billion. The portfolio is valued at $152,000 per unit, representing a discount to estimated replacement cost in excess of 30%. Atria Senior Living assumed operations of the portfolio following its acquisition of the Holiday management company.

StoryPoint Senior Living We expanded our relationship with StoryPoint through the acquisition of 11 seniors housing communities located across the Midwest for $274 million. These properties will be operated by StoryPoint under a triple-net master lease.

Safanad/HC-One Loan Funding and Equity Investment During the second quarter, we provided £540 million ($750 million) of senior loan financing and a £30 million ($42 million) delayed facility to affiliates of Safanad, a global real estate and private equity firm, as part of the successful recapitalization of its investment in HC-One Group. The loan has a 5-year term and is fully collateralized by the shares and assets of the HC-One Group, including its underlying property portfolio of owned assets across the United Kingdom. Welltower's last pound basis on the initial £540 million investment is approximately £40,000 per unit.

Genesis Update During the first quarter, we entered into a definitive agreement to execute a series of mutually beneficial transactions resulting in the substantial exit of Welltower's operating relationship with Genesis. As of December 31, 2021, we have closed on the transitions of nine PowerBack facilities to an 80/20 joint venture with ProMedica, which occurred in April and generated pro rata proceeds of $58 million. Additionally, operations have transitioned for 39 of the remaining 42 properties, with three properties expected to transition at a later date. We have entered into definitive agreements to sell the 42 properties to either a joint venture with Aurora Health Network, the new operator and us, or to sell outright. As of December 31, 2021, we have closed on the sale of 25 of these properties for proceeds of $379 million. An additional ten properties are classified as held for sale and the remaining seven properties are expected to be sold in 2023.

Investment Activity Subsequent to Quarter End Subsequent to the end of the fourth quarter, we closed an additional $600 million of pro rata acquisitions and loan funding across four separate transactions, including a portfolio of eight class-A private pay seniors housing communities with an average age of 11 years. The investments are expected to generate high single digit unlevered IRRs.

Outlook for First Quarter 2022 The degree to which the COVID-19 pandemic continues to impact our operations and those of our operators and tenants, including the variability in the timing of recovery, is dependent on a variety of factors and remains highly uncertain. Accordingly, we are only introducing earnings guidance for the quarter ended March 31, 2022 and expect to report net income attributable to common stockholders in a range of $0.17 to $0.22 per diluted share and normalized FFO attributable to common stockholders in a range of $0.79 to $0.84 per diluted share. In preparing our guidance, we have made the following assumptions:

  • Same Store NOI: We expect average blended SSNOI growth of 7.0%, which is comprised of the following components:
    • Seniors Housing Operating approximately 15.0%
    • Seniors Housing Triple-net approximately 5.0% to 6.0%
    • Outpatient Medical approximately 1.0% to 2.0%
    • Health System approximately 2.75%
    • Long-Term/Post-Acute Care approximately 1.0% to 2.0%
  • Provider Relief Funds: Our first quarter guidance includes approximately $6 million of Provider Relief Funds which are expected to be received during the quarter.
  • General and Administrative Expenses: We anticipate first quarter general and administrative expenses to be approximately $35 million to $37 million and stock-based compensation expense to be approximately $7 million.
  • Investments: Our earnings guidance includes only those acquisitions closed or announced to date. Furthermore, no transitions or restructures beyond those announced to date are included.
  • Development: We anticipate funding approximately $728 million of development in 2022 relating to projects underway on December 31, 2021.
  • Dispositions: We expect pro rata disposition proceeds of $220 million at a blended yield of 5.3% in 2022. This includes approximately $161 million of expected proceeds from properties classified as held-for-sale as of December 31, 2021 and $59 million in expected loan payoffs.

Our guidance does not include any additional investments, dispositions or capital transactions beyond those we have announced, nor any other expenses, impairments, unanticipated additions to the loan loss reserve or other additional normalizing items. Please see the Supplemental Reporting Measures section for further discussion and our definition of normalized FFO and SSNOI and Exhibit 3 for a reconciliation of the outlook for net income available to common stockholders to normalized FFO attributable to common stockholders. We will provide additional detail regarding our first quarter outlook and assumptions on the fourth quarter 2021 conference call.

Conference Call Information We have scheduled a conference call on Wednesday, February 16, 2022 at 9:00 a.m. Eastern Time to discuss our fourth quarter 2021 results, industry trends and portfolio performance. Telephone access will be available by dialing (844) 467-7115 or (409) 983-9837 (international). For those unable to listen to the call live, a taped rebroadcast will be available beginning two hours after completion of the call through March 2, 2022. To access the rebroadcast, dial (855) 859-2056 or (404) 537-3406 (international). The conference ID number is 2198105. To participate in the webcast, log on to www.welltower.com 15 minutes before the call to download the necessary software. Replays will be available for 90 days.

Supplemental Reporting Measures We believe that net income and net income attributable to common stockholders ("NICS"), as defined by U.S. generally accepted accounting principles ("U.S. GAAP"), are the most appropriate earnings measurements. However, we consider funds from operations ("FFO"), normalized FFO, NOI, SSNOI, REVPOR and SS REVPOR to be useful supplemental measures of our operating performance. These supplemental measures are disclosed on our pro rata ownership basis. Pro rata amounts are derived by reducing consolidated amounts for minority partners' noncontrolling ownership interests and adding our minority ownership share of unconsolidated amounts. We do not control unconsolidated investments. While we consider pro rata disclosures useful, they may not accurately depict the legal and economic implications of our joint venture arrangements and should be used with caution.

Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts ("NAREIT") created FFO as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO attributable to common stockholders, as defined by NAREIT, means net income attributable to common stockholders, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairments of depreciable assets, plus real estate depreciation and amortization, and after adjustments for unconsolidated entities and noncontrolling interests. Normalized FFO attributable to common stockholders represents FFO attributable to common stockholders adjusted for certain items detailed in Exhibit 2. We believe that normalized FFO attributable to common stockholders is a useful supplemental measure of operating performance because investors and equity analysts may use this measure to compare the operating performance of the Company between periods or as compared to other REITs or other companies on a consistent basis without having to account for differences caused by unanticipated and/or incalculable items.

We define NOI as total revenues, including tenant reimbursements, less property operating expenses. Property operating expenses represent costs associated with managing, maintaining and servicing tenants for our properties. These expenses include, but are not limited to, property-related payroll and benefits, property management fees paid to operators, marketing, housekeeping, food service, maintenance, utilities, property taxes and insurance. General and administrative expenses represent costs unrelated to property operations or transaction costs. These expenses include, but are not limited to, payroll and benefits, professional services, office expenses and depreciation of corporate fixed assets. SSNOI is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. As used herein, same store is generally defined as those revenue-generating properties in the portfolio for the relevant year-over-year reporting periods. Acquisitions and development conversions are included in the same store amounts five full quarters after acquisition or being placed into service. Land parcels, loans and sub-leases, as well as any properties sold or classified as held for sale during the period, are excluded from the same store amounts. Redeveloped properties (including major refurbishments of a Seniors Housing Operating property where 20% or more of units are simultaneously taken out of commission for 30 days or more or Outpatient Medical properties undergoing a change in intended use) are excluded from the same store amounts until five full quarters post completion of the redevelopment. Properties undergoing operator transitions and/or segment transitions are also excluded from the same store amounts until five full quarters post completion of the operator transition or segment transition. In addition, properties significantly impacted by force majeure, acts of God or other extraordinary adverse events are excluded from same store amounts until five full quarters after the properties are placed back into service. SSNOI excludes non-cash NOI and includes adjustments to present consistent property ownership percentages and to translate Canadian properties and UK properties using a consistent exchange rate. Normalizers include adjustments that in management's opinion are appropriate in considering SSNOI, a supplemental, non-GAAP performance measure. None of these adjustments, which may increase or decrease SSNOI, are reflected in our financial statements prepared in accordance with U.S. GAAP. Significant normalizers (defined as any that individually exceed 0.50% of SSNOI growth per property type) are separately disclosed and explained. We believe NOI and SSNOI provide investors relevant and useful information because they measure the operating performance of our properties at the property level on an unleveraged basis. We use NOI and SSNOI to make decisions about resource allocations and to assess the property level performance of our properties. No reconciliation of the forecasted range for SSNOI on a combined basis or by property type is included in this release because we are unable to quantify certain amounts that would be required to be included in the comparable GAAP financial measure without unreasonable efforts, and we believe such reconciliation would imply a degree of precision that could be confusing or misleading to investors.

REVPOR represents the average revenues generated per occupied room per month at our Seniors Housing Operating properties. It is calculated as our pro rata version of total resident fees and services revenues from the income statement divided by average monthly occupied room days. SS REVPOR is used to evaluate the REVPOR performance of our properties under a consistent population which eliminates changes in the composition of our portfolio. It is based on the same pool of properties used for SSNOI and includes any revenue normalizations used for SSNOI. We use REVPOR and SS REVPOR to evaluate the revenue-generating capacity and profit potential of our Seniors Housing Operating portfolio independent of fluctuating occupancy rates. They are also used in comparison against industry and competitor statistics, if known, to evaluate the quality of our Seniors Housing Operating portfolio.

Our supplemental reporting measures and similarly entitled financial measures are widely used by investors, equity and debt analysts and ratings agencies in the valuation, comparison, rating and investment recommendations of companies. Our management uses these financial measures to facilitate internal and external comparisons to historical operating results and in making operating decisions. Additionally, they are utilized by the Board of Directors to evaluate management. The supplemental reporting measures do not represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the supplemental reporting measures, as defined by us, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies. Please see the exhibits for reconciliations of supplemental reporting measures and the supplemental information package for the quarter ended December 31, 2021, which is available on the Company's website (www.welltower.com), for information and reconciliations of additional supplemental reporting measures.

About Welltower Welltower Inc. (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower™, a real estate investment trust ("REIT"), owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties. More information is available at www.welltower.com. We routinely post important information on our website at www.welltower.com in the "Investors" section, including corporate and investor presentations and financial information. We intend to use our website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Such disclosures will be included on our website under the heading "Investors". Accordingly, investors should monitor such portion of our website in addition to following our press releases, public conference calls and filings with the Securities and Exchange Commission. The information on our website is not incorporated by reference in this press release, and our web address is included as an inactive textual reference only.

Forward-Looking Statements and Risk Factors This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. When Welltower uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "pro forma," "estimate" or similar expressions that do not relate solely to historical matters, Welltower is making forward-looking statements. Forward-looking statements, including statements related to Funds From Operations guidance, are not guarantees of future performance and involve risks and uncertainties that may cause Welltower's actual results to differ materially from Welltower's expectations discussed in the forward-looking statements. This may be a result of various factors, including, but not limited to: the impact of the COVID-19 pandemic; uncertainty regarding the implementation and impact of the CARES Act and future stimulus or other COVID-19 relief legislation; the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators'/tenants' difficulty in cost effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and seniors housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; Welltower's ability to transition or sell properties with profitable results; the failure to make new investments or acquisitions as and when anticipated; natural disasters and other acts of God affecting Welltower's properties; Welltower's ability to re-lease space at similar rates as vacancies occur; Welltower's ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future investments or acquisitions; environmental laws affecting Welltower's properties; changes in rules or practices governing Welltower's financial reporting; the movement of U.S. and foreign currency exchange rates; Welltower's ability to maintain its qualification as a REIT; key management personnel recruitment and retention; and other risks described in Welltower's reports filed from time to time with the SEC. Welltower undertakes no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, or to update the reasons why actual results could differ from those projected in any forward-looking statements.

Welltower Inc.

Financial Exhibits


Consolidated Balance Sheets (unaudited)

(in thousands)



December 31,



2021


2020

Assets





Real estate investments:





Land and land improvements


$                      3,968,430


$                      3,440,650

Buildings and improvements


31,062,203


28,024,971

Acquired lease intangibles


1,789,628


1,500,030

Real property held for sale, net of accumulated depreciation


134,097


216,613

Construction in progress


651,389


487,742

Less accumulated depreciation and intangible amortization


(6,910,114)


(6,104,297)

Net real property owned


30,695,633


27,565,709

Right of use assets, net


522,796


465,866

Real estate loans receivable, net of credit allowance


1,068,681


443,372

Net real estate investments


32,287,110


28,474,947

Other assets:





Investments in unconsolidated entities


1,039,043


946,234

Goodwill


68,321


68,321

Cash and cash equivalents


269,265


1,545,046

Restricted cash


77,490


475,997

Straight-line rent receivable


365,643


344,066

Receivables and other assets


803,453


629,031

Total other assets


2,623,215


4,008,695

Total assets


$                    34,910,325


$                    32,483,642






Liabilities and equity





Liabilities:





Unsecured credit facility and commercial paper


$                         324,935


$                                  —

Senior unsecured notes


11,613,758


11,420,790

Secured debt


2,192,261


2,377,930

Lease liabilities


545,944


418,266

Accrued expenses and other liabilities


1,235,554


1,041,594

Total liabilities


15,912,452


15,258,580

Redeemable noncontrolling interests


401,294


343,490

Equity:





Common stock


448,605


418,691

Capital in excess of par value


23,133,641


20,823,145

Treasury stock


(107,750)


(104,490)

Cumulative net income


8,663,736


8,327,598

Cumulative dividends


(14,380,915)


(13,343,721)

Accumulated other comprehensive income


(121,316)


(148,504)

Total Welltower Inc. stockholders' equity


17,636,001


15,972,719

Noncontrolling interests


960,578


908,853

Total equity


18,596,579


16,881,572

Total liabilities and equity


$                    34,910,325


$                    32,483,642


 

Consolidated Statements of Income (unaudited)





(in thousands, except per share data)









Three Months Ended


Twelve Months Ended





December 31,


December 31,





2021


2020


2021


2020

Revenues:











Resident fees and services


$           897,251


$           713,534


$        3,197,223


$        3,074,022



Rental income


359,145


382,049


1,374,695


1,443,360



Interest income


39,672


21,096


137,563


69,156



Other income


13,196


5,337


32,634


19,429



Total revenues


1,309,264


1,122,016


4,742,115


4,605,967

Expenses:











Property operating expenses


785,179


620,561


2,774,562


2,597,823



Depreciation and amortization


284,501


242,733


1,037,566


1,038,437



Interest expense


121,848


121,173


489,853


514,388



General and administrative expenses


33,109


27,848


126,727


128,394



Loss (gain) on derivatives and financial instruments, net


(830)


569


(7,333)


11,049



Loss (gain) on extinguishment of debt, net


(1,090)


13,796


49,874


47,049



Provision for loan losses, net


(39)


83,085


7,270


94,436



Impairment of assets


2,357


9,317


51,107


135,608



Other expenses


15,483


33,088


41,739


70,335



Total expenses


1,240,518


1,152,170


4,571,365


4,637,519

Income (loss) from continuing operations before income taxes











and other items


68,746


(30,154)


170,750


(31,552)

Income tax (expense) benefit


(2,051)


(290)


(8,713)


(9,968)

Income (loss) from unconsolidated entities


(12,174)


258


(22,933)


(8,083)

Gain (loss) on real estate dispositions, net


11,673


185,464


235,375


1,088,455

Income (loss) from continuing operations


66,194


155,278


374,479


1,038,852










Net income (loss)


66,194


155,278


374,479


1,038,852

Less:


Net income (loss) attributable to noncontrolling interests (1)


7,522


(8,451)


38,341


60,008

Net income (loss) attributable to common stockholders


$             58,672


$           163,729


$           336,138


$           978,844

Average number of common shares outstanding:











Basic


436,909


417,123


424,976


415,451



Diluted


438,719


418,753


426,841


417,387

Net income (loss) attributable to common stockholders per share:











Basic


$                 0.13


$                 0.39


$                 0.79


$                 2.36



Diluted(2)


$                 0.13


$                 0.39


$                 0.78


$                 2.33

Common dividends per share


$                 0.61


$                 0.61


$                 2.44


$                 2.70












(1) Includes amounts attributable to redeemable noncontrolling interests.

(2) Includes adjustment to the numerator for income (loss) attributable to OP unitholders.

 

FFO Reconciliations








Exhibit 1


(in thousands, except per share data)


Three Months Ended


Twelve Months Ended







December 31,


December 31,







2021


2020


2021


2020


Net income (loss) attributable to common stockholders


$         58,672


$       163,729


$       336,138


$       978,844


Depreciation and amortization


284,501


242,733


1,037,566


1,038,437


Impairments and losses (gains) on real estate dispositions, net


(9,316)


(176,147)


(184,268)


(952,847)


Noncontrolling interests(1)


(13,988)


(20,579)


(54,190)


(23,968)


Unconsolidated entities(2)


19,107


16,091


85,476


62,096


NAREIT FFO attributable to common stockholders


338,976


225,827


1,220,722


1,102,562


Normalizing items, net(3)


23,136


125,468


147,816


381,618


Normalized FFO attributable to common stockholders


$       362,112


$       351,295


$    1,368,538


$    1,484,180















Average diluted common shares outstanding


438,719


418,753


426,841


417,387















Per diluted share data attributable to common stockholders:











Net income (loss)(4)


$             0.13


$             0.39


$             0.78


$             2.33



NAREIT FFO


$             0.77


$             0.54


$             2.86


$             2.64



Normalized FFO


$             0.83


$             0.84


$             3.21


$             3.56















Normalized FFO Payout Ratio:











Dividends per common share


$             0.61


$             0.61


$             2.44


$             2.70



Normalized FFO attributable to common stockholders per share


$             0.83


$             0.84


$             3.21


$             3.56




Normalized FFO payout ratio


73%


73 %


76%


76%















Other items:(5)










Net straight-line rent and above/below market rent amortization(6)


$        (18,792)


$        (21,640)


$        (77,464)


$        (90,926)


Non-cash interest expenses(7)


7,027


2,108


21,599


11,545


Recurring cap-ex, tenant improvements, and lease commissions


(46,344)


(21,634)


(100,925)


(81,271)


Stock-based compensation(8)


2,945


1,875


16,934


22,154




(1) Represents noncontrolling interests' share of net FFO adjustments.


(2) Represents Welltower's share of net FFO adjustments from unconsolidated entities.


(3) See Exhibit 2.


(4) Includes adjustment to the numerator for income (loss) attributable to OP unitholders.


(5) Amounts presented net of noncontrolling interests' share and including Welltower's share of unconsolidated entities.


(6) Excludes normalized other impairment (see Exhibit 2).


(7) Excludes normalized incremental interest expense (see Exhibit 2).


(8) Excludes certain severance related stock-based compensation recorded in other expense (see Exhibit 2).



 

Normalizing Items







Exhibit 2


(in thousands, except per share data)



Three Months Ended


Twelve Months Ended





December 31,


December 31,





2021


2020


2021


2020


Loss (gain) on derivatives and financial instruments, net


$       (830)

(1)

$        569


$    (7,333)


$   11,049


Loss (gain) on extinguishment of debt, net


(1,090)

(2)

13,796


49,874


47,049


Provision for loan losses, net


(39)

(3)

83,085


7,270


94,436


Nonrecurring income tax benefits




(6,298)



Incremental interest expense





5,871


Other impairment




49,241


146,508


Other expenses


15,483

(4)

33,088


41,739


70,335


Leasehold interest adjustment


1,400

(5)


760



Casualty losses, net of recoveries



4,788

(6)


5,786



Normalizing items attributable to noncontrolling interests and unconsolidated entities, net


3,424

(7)

(5,070)


6,777


6,370


Net normalizing items


$   23,136


$ 125,468


$ 147,816


$ 381,618













Average diluted common shares outstanding


438,719


418,753


426,841


417,387


Net normalizing items per diluted share


$       0.05


$       0.30


$       0.35


$       0.91













(1) Primarily related to mark-to-market of the equity warrants received as part of the Safanad/HC-One transaction that closed in the second quarter.


(2) Primarily related to the extinguishment of secured debt


(3) Primarily related to reserves for loan losses under the current expected credit losses accounting standard.


(4) Primarily related to non-capitalizable transaction costs, including an accrual for non-capitalizable promotes, and legal fees and accrued litigation settlements.


(5) Represents $14,774,000 of revenues and $16,174,000 of property operating expenses associated with a leasehold portfolio interest relating to 26 properties assumed by a wholly-owned affiliate in conjunction with the Holiday Retirement transaction. Subsequent to the initial transaction, we purchased eight of the leased properties and one of the properties was sold by the landlord and removed from the lease. No rent will be paid in excess of net cash flow relating to the leasehold properties and therefore, the net impact each quarter will be excluded from Normalized FFO.


(6) Primarily relates to casualty losses net of any insurance recoveries.


(7) Primarily related to our share of accrued litigation settlements and non-capitalizable transaction costs on unconsolidated entities.



Outlook Reconciliation: Quarter Ending March 31, 2022

Exhibit 3


(in millions, except per share data)




Current Outlook






Low


High


FFO Reconciliation:







Net income attributable to common stockholders



$                     78


$                   101


Impairments and losses (gains) on real estate dispositions, net(1,2)



(30)


(30)


Depreciation and amortization(1)



309


309


NAREIT FFO and Normalized FFO attributable to common stockholders



357


380










Diluted per share data attributable to common stockholders:







Net income



$                  0.17


$                  0.22


NAREIT FFO and Normalized FFO



$                  0.79


$                  0.84










Other items:(1)







Net straight-line rent and above/below market rent amortization



$                    (20)


$                    (20)


Non-cash interest expenses



5


5


Recurring cap-ex, tenant improvements, and lease commissions



(27)


(27)


Stock-based compensation



8


8





(1) Amounts presented net of noncontrolling interests' share and Welltower's share of unconsolidated entities.


(2) Includes estimated gains on expected dispositions.



 

Reconciliation of SHO SS REVPOR Growth






Exhibit 4


(in thousands except SS REVPOR)


Three Months Ended


Three Months Ended




December 31,


September 30,


September 30,




2021


2020


2021


2020


Consolidated SHO revenues


$             904,780


$             715,020


$             839,519


$                 742,065


Unconsolidated SHO revenues attributable to WELL(1)


47,836


43,175


45,991


42,574


SHO revenues attributable to noncontrolling interests(2)


(75,052)


(55,155)


(73,414)


(58,505)


SHO pro rata revenues(3)


877,564


703,040


812,096


726,134


Non-cash revenues on same store properties


(562)


(851)


(562)


(848)


Revenues attributable to non-same store properties


(240,544)


(102,016)


(142,217)


(54,813)


Currency and ownership adjustments(4)


514


3,801


(448)


2,266


Normalizing adjustment for government grants(5)


(4,406)





Other normalizing adjustments(6)


(383)


(549)



(1,481)


SHO SS revenues(7)


$             632,183


$             603,425


$             668,869


$                 671,258


SHO SS revenue YOY growth


4.8%




(0.4)%




Average occupied units/month(8)


38,686


38,190


39,716


40,736


SHO SS REVPOR(9)


$                 5,403


$                 5,224


$                 5,568


$                     5,448


SS REVPOR YOY growth


3.4%




2.2%














(1) Represents Welltower's interests in joint ventures where Welltower is the minority partner.






(2) Represents minority partners' interests in joint ventures where Welltower is the majority partner and includes an adjustment to remove revenues related to certain leasehold properties. See Exhibit 2 for more information.


(3) Represents SHO revenues at Welltower pro rata ownership.






(4) Includes where appropriate adjustments to reflect consistent property ownership percentages, to translate Canadian properties at a USD/CAD rate of 1.2684 and to translate UK properties at a GBP/USD rate of 1.38.


(5) Represents normalizing adjustment related to amounts recognized related to the Health and Human Services Provider Relief Fund in the United States and similar programs in the United Kingdom and Canada.


(6) Represents aggregate normalizing adjustments which are individually less than .50% of SSNOI growth.


(7) Represents SS SHO revenues at Welltower pro rata ownership.


(8) Represents average occupied units for SS properties on a pro rata basis.


(9) Represents pro rata SS average revenues generated per occupied room per month.


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/welltower-reports-fourth-quarter-2021-results-301483027.html

SOURCE Welltower Inc.

FAQ

What were Welltower's Q4 2021 earnings per share?

Welltower reported a net income of $0.13 per diluted share for Q4 2021.

What is Welltower's normalized FFO for Q4 2021?

The normalized FFO for Welltower in Q4 2021 was $0.83 per diluted share.

How much did Welltower invest in 2021?

Welltower completed $5.7 billion of pro rata gross investments in 2021.

What is Welltower's expected net income for Q1 2022?

Welltower expects its net income for Q1 2022 to be between $0.17 to $0.22 per diluted share.

What factors affected Welltower's Q4 2021 expenses?

Welltower's Q4 2021 expenses increased significantly due to COVID-19 related costs.

Welltower Inc.

NYSE:WELL

WELL Rankings

WELL Latest News

WELL Stock Data

84.67B
622.69M
0.09%
95.81%
1.39%
REIT - Healthcare Facilities
Retail-nonstore Retailers
Link
United States of America
EAST MEADOW